The device was cleared for the market by the FDA in 2020, the company said Feb. 22. Implanet began promoting the device in late 2021 after it acquired French company Orthopaedic & Spine Development.
Implanet has sold more than 7,000 of the cervical plates.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.